Gerard P. Devlin

Jun 14, 2024 | bmjopen.bmj.com | John Pickering |Gerard P. Devlin |Richard Body |Sally J. Aldous

Intervention-evaluation phaseIn the intervention phase, the only modification to the decision-making logic of existing usual-care clinical pathways is the use of a POC-cTnI measurement within the ED in place of the central laboratory hs-cTn measurement. The intervention will remain in place in all sites for a minimum 4 months following the end of the run-in period at the final site(s). POC-TnI will be the preferential troponin test used in the ED instead of central laboratory cTn testing.